BACKGROUND Emerging evidence shows that severe COVID-19 can be complicated by a
significant coagulopathy, that likely manifests in the form of both microthrombosis and …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months,
causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation …

Background Emerging evidence shows that severe coronavirus disease 2019 (COVID-19)
can be complicated by a significant coagulopathy, that likely manifests in the form of both …

ABSTRACT COVID-19 pneumonia has been associated with high rates of thrombo-embolic
complications, mostly venous thromboembolism (VTE), which is thought to be a combination …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

Background Venous thromboembolism (VTE) may complicate the course of Coronavirus
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …

Abstract Purpose of Review Novel coronavirus disease 2019 (COVID-19) has been
associated with an increased risk of arterial and venous thromboembolic (VTE) diseases …

Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE)
events in coronavirus disease 2019 (COVID-19) patients, especially in those who are …

Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

Background Venous thromboembolism (VTE) is frequently observed in patients with
coronavirus disease 2019 (COVID‐19). However, reported VTE rates differ substantially …